Webcast Alert: Aastrom to Host Investor Conference Call on Critical Limb Ischemia and Related Clinical Development Progress
Ann Arbor, Michigan, May 3, 2010 (3:20 pm ET) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following webcast:
| What: | Investor conference call to present an update on clinical development efforts related to critical limb ischemia (CLI). The event will also feature a Q&A session with Anthony J. Comerota, MD, FACS, FACC, director of the Jobst Vascular Center in Toledo, Ohio. |
| When: | Monday, May 10, 2010 @ 1:00 pm (ET) |
| Where: | http://www.investorcalendar.com/IC/CEPage.asp?ID=158215 |
| How: |
|
If you are unable to participate during the live call, the webcast will be available for replay at http://www.investorcalendar.com/ until August 10, 2010. Through May 24, 2010, the audio replay of the call will be available by dialing toll-free (877) 660-6853, or from outside the U.S. (201) 612-7415. When prompted on the phone, the Account # is: 286, and the Conference ID# is: 350255.
About Aastrom Biosciences
Aastrom Biosciences is developing autologous cellular therapies for use in the treatment of severe cardiovascular diseases. The company's proprietary cell-processing technology enables the production of cellular therapies using a patient's own bone marrow that can be delivered directly to damaged tissues. Aastrom has advanced this technology into late-stage clinical development and is conducting two Phase 2 clinical trials to treat dilated cardiomyopathy and a Phase 2b clinical trial to treat critical limb ischemia. For more information, please visit Aastrom's website at www.aastrom.com.
Media contact
Stephen Zoegall
Berry & Company
212 253-8881
szoegall@berrypr.com
Investor Contact
Kimberli O'Meara
Aastrom Biosciences
734 930-5777
ir@aastrom.com
